These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

73 related items for PubMed ID: 6822639

  • 1. Dopaminergic modulation of meal-stimulated and circadian secretion of pancreatic polypeptide in man.
    Stern N, Sowers JR, Taylor IL, Golub M.
    J Clin Endocrinol Metab; 1983 Feb; 56(2):300-4. PubMed ID: 6822639
    [Abstract] [Full Text] [Related]

  • 2. Evidence for dopaminergic modulation of pancreatic polypeptide secretion in man.
    Sowers JR, Stern N, Taylor IL.
    Life Sci; 1982 Dec 27; 31(26):2971-5. PubMed ID: 7162360
    [Abstract] [Full Text] [Related]

  • 3. Cholinergic independent dopaminergic regulation of motilin release in man.
    Funakoshi A, Matsumoto M, Sekiya K, Nakano I, Shinozaki H, Ibayashi H.
    Gastroenterol Jpn; 1983 Dec 27; 18(6):525-9. PubMed ID: 6671510
    [Abstract] [Full Text] [Related]

  • 4. Influence of sodium homeostasis and circadian rhythm on dopaminergic modulation of 18-hydroxycorticosterone secretion in man.
    Sowers JR, Stern N.
    J Clin Endocrinol Metab; 1982 Dec 27; 55(6):1046-51. PubMed ID: 7130335
    [Abstract] [Full Text] [Related]

  • 5. Effects of metoclopramide and bromocriptine on the renin-angiotensin-aldosterone system in man. Dopaminergic control of aldosterone.
    Carey RM, Thorner MO, Ortt EM.
    J Clin Invest; 1979 Apr 27; 63(4):727-35. PubMed ID: 438333
    [Abstract] [Full Text] [Related]

  • 6. Dopaminergic stimulation and inhibition of growth hormone secretion in normal man: studies of the pharmacologic specificity.
    Bansal SA, Lee LA, Woolf PD.
    J Clin Endocrinol Metab; 1981 Dec 27; 53(6):1273-7. PubMed ID: 7028777
    [Abstract] [Full Text] [Related]

  • 7. Stimulation of pancreatic polypeptide and glucagon secretion by 2-deoxy-D-glucose in man: evidence for cholinergic mediation.
    Hedo JA, Villanueva ML, Marco J.
    J Clin Endocrinol Metab; 1978 Aug 27; 47(2):366-71. PubMed ID: 400718
    [Abstract] [Full Text] [Related]

  • 8. Dopaminergic inhibition of metoclopramide-induced aldosterone secretion in man. Dissociation of responses to dopamine and bromocriptine.
    Carey RM, Thorner MO, Ortt EM.
    J Clin Invest; 1980 Jul 27; 66(1):10-8. PubMed ID: 7400305
    [Abstract] [Full Text] [Related]

  • 9. Control of pancreatic polypeptide secretion by glucose in man.
    Marco J, Hedo JA, Villanueva ML.
    J Clin Endocrinol Metab; 1978 Jan 27; 46(1):140-5. PubMed ID: 752016
    [Abstract] [Full Text] [Related]

  • 10. Dopaminergic modulation of circadian thyrotropin rhythms and thyroid hormone levels in euthyroid subjects.
    Scanlon MF, Weetman AP, Lewis M, Pourmand M, Rodriguez-Arnao MD, Weightman DR, Hall R.
    J Clin Endocrinol Metab; 1980 Dec 27; 51(6):1251-6. PubMed ID: 7440694
    [Abstract] [Full Text] [Related]

  • 11. Dopaminergic mechanisms and luteinizing hormone (LH) secretion. II. Differential effects of dopamine and bromocriptine on LH release in normal women.
    Martin WH, Rogol AD, Kaiser DL, Thorner MO.
    J Clin Endocrinol Metab; 1981 Apr 27; 52(4):650-6. PubMed ID: 7204538
    [Abstract] [Full Text] [Related]

  • 12. Human pancreatic polypeptide: studies of fasting and postprandial plasma concentrations.
    Track NS, McLeod RS, Mee AV.
    Can J Physiol Pharmacol; 1980 Dec 27; 58(12):1484-9. PubMed ID: 7237243
    [Abstract] [Full Text] [Related]

  • 13. Diabetic autonomic neuropathy and impaired human pancreatic polypeptide secretion in response to food.
    Lugari R, Gnudi A, Dall'Argine P, Vattini A, Rignanese G, Dall'Aglio B, Melchionda N, Colella P, Luciani A, Toscani S.
    J Clin Endocrinol Metab; 1987 Feb 27; 64(2):279-82. PubMed ID: 3793851
    [Abstract] [Full Text] [Related]

  • 14. The effect of metoclopramide and dopamine on plasma aldosterone concentration in normal man and rhesus monkeys (Macaca mulatta): a new model to study dopamine control of aldosterone secretion.
    Brown RD, Billman GE, Kem DC, Stone HL, Jiang NS, Kao P, Hegstad RL.
    J Clin Endocrinol Metab; 1982 Nov 27; 55(5):828-32. PubMed ID: 7119085
    [Abstract] [Full Text] [Related]

  • 15. Evidence for dopaminergic control of circadian variations in thyrotropin secretion.
    Sowers JR, Catania RA, Hershman JM.
    J Clin Endocrinol Metab; 1982 Apr 27; 54(4):673-5. PubMed ID: 7061686
    [Abstract] [Full Text] [Related]

  • 16. Exaggerated circadian variation in basal thyrotropin (TSH) and in the dopaminergic inhibition of TSH release in pathological hyperprolactinemia: evidence against a hypothalamic dopaminergic defect.
    Rodriguez-Arnao MD, Peters JR, Foord SM, Dieguez C, Edwards C, Gomez-Pan A, Hall R, Newcombe RG, Scanlon MF.
    J Clin Endocrinol Metab; 1983 Nov 27; 57(5):975-80. PubMed ID: 6619271
    [Abstract] [Full Text] [Related]

  • 17. Adrenergic modulation of human pancreatic polypeptide (hPP) release.
    Sive AA, Vinik AI, Levitt N.
    Gastroenterology; 1980 Oct 27; 79(4):665-72. PubMed ID: 6997131
    [Abstract] [Full Text] [Related]

  • 18. Response of pancreatic polypeptide to a protein rich meal in diabetic autonomic neuropathy.
    Weil R, Mineur P, Ketelslegers JM, Assal JP, Lambert AE.
    Diabete Metab; 1989 Oct 27; 15(4):163-9. PubMed ID: 2806702
    [Abstract] [Full Text] [Related]

  • 19. Human pancreatic polypeptide: studies in fasting and in the growth hormone deficient state.
    Loo SW, Gabbay KH, Merimee TJ.
    Horm Metab Res; 1980 Aug 27; 12(8):361-3. PubMed ID: 6997163
    [Abstract] [Full Text] [Related]

  • 20. Dopaminergic modulation of 18-hydroxycorticosterone secretion in man.
    Sowers JR, Berg G, Tuck ML, Martin VI, Chandler DW, Mayes DM.
    J Clin Endocrinol Metab; 1982 Mar 27; 54(3):523-7. PubMed ID: 7035483
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 4.